Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ganymede Bio is a life science software company that provides a cloud-based data and automation platform for laboratories and biomanufacturing environments. Its platform connects lab instruments, ELN/LIMS, analytical applications, and other software into a unified FAIR data layer, enabling automated data capture, analysis, and workflow orchestration. The company emphasizes modular, developer-friendly infrastructure, including its "Lab-as-Code" approach and GxP-native capabilities for regulated environments. Ganymede serves biotech, diagnostics, and manufacturing teams across workflows such as bioprocessing, chromatography, qPCR, liquid handling, and plate-based assays. In January 2026, Ganymede was acquired by Apprentice.io, and its products continue to be offered as part of the broader Apprentice platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ganymede Bio.